Is PCRBF or JNJ a better dividend investment in 2026?

PCRBF currently yields 588.24% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: PCRBF offers higher current income.

What is the dividend yield difference between PCRBF and JNJ?

PCRBF has a forward dividend yield of 588.24% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 584.88 percentage points.

Home › Compare › PCRBF vs JNJ

PCRBF vs JNJ: Dividend Comparison 2026

PCRBF yields 588.24% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PCRBF wins by $415.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

PCRBF

● Live price

588.24%

Share price

$0.34

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$435.9K

Annual income

$1,269.13

Full PCRBF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — PCRBF vs JNJ

📍 PCRBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PCRBF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PCRBF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PCRBF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCRBF

Annual income on $10K today (after 15% tax)

$50,000.00/yr

After 10yr DRIP, annual income (after tax)

$1,078.76/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, PCRBF beats the other by $375.15/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCRBF + JNJ for your $10,000?

PCRBF: 50%JNJ: 50%

100% JNJ50/50100% PCRBF

Portfolio after 10yr

$227.9K

Annual income

$1,048.46/yr

Blended yield

0.46%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PCRBF

No analyst data

Altman Z

2.1

Piotroski

5/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCRBF buys

JNJ buys

No recent congressional trades found for PCRBF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPCRBFJNJ

Forward yield	588.24% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	-50%	5.8% ✓
Portfolio after 10y	$435.9K ✓	$20.0K
Annual income after 10y	$1,269.13 ✓	$827.78
Total dividends collected	$266.8K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: PCRBF vs JNJ ($10,000, DRIP)

Year	PCRBF Portfolio	PCRBF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$40,112	$29,411.76	$10,676	$355.77	+$29.4K → PCRBF
2	$98,048	$55,128.87	$11,407	$389.39	+$86.6K → PCRBF
3	$167,882	$62,970.09	$12,198	$426.53	+$155.7K → PCRBF
4	$230,017	$50,382.97	$13,056	$467.62	+$217.0K → PCRBF
5	$278,375	$32,257.09	$13,987	$513.12	+$264.4K → PCRBF
6	$316,104	$18,242.41	$14,998	$563.56	+$301.1K → PCRBF
7	$347,911	$9,679.83	$16,098	$619.52	+$331.8K → PCRBF
8	$377,243	$4,978.43	$17,295	$681.69	+$359.9K → PCRBF
9	$406,172	$2,522.50	$18,599	$750.82	+$387.6K → PCRBF
10	$435,874	$1,269.13	$20,022	$827.78	+$415.9K → PCRBF

PCRBF vs JNJ: Complete Analysis 2026

PCRBF — Stock

Pricer AB (publ) manufactures electronic shelf labels in Sweden, France, Italy, the United States, Norway, and internationally. The company offers digital pricing tags, such as graphic and segment price tags; and attachments. It provides electronic shelf label platforms; Pricer Plaza, a cloud-based platform for the complete scalable management, monitoring, and integration of a digital in-store system; and The Pricer platform, an in-store digital platform. The company markets and sells its products through direct sales and resellers. Pricer AB (publ) was incorporated in 1991 and is headquartered in Stockholm, Sweden.

Full PCRBF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this PCRBF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCRBF vs SCHD PCRBF vs JEPI PCRBF vs O PCRBF vs KO PCRBF vs MAIN PCRBF vs ABBV PCRBF vs MRK PCRBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.